Airsupra July 5, 2023 On January 2023, the FDA approved the use of Airsupra, a rescue combination inhaler containing albuterol and budesonide. Traditionally, the only class of drugs used in rescue inhalers are SABAs (short-acting beta agonists), Read More
Compounding Pharmacies vs. Big Pharma: The Battle for Dominance in the Growing GLP-1 Market October 22, 2024
